LON:4BB 4basebio (4BB) Share Price, News & Analysis GBX 1,410 -40.00 (-2.76%) (As of 09/6/2024 11:37 AM ET) Add Compare Share Share Today's Range 1,400▼ 1,41050-Day Range 1,288.40▼ 1,59952-Week Range 492▼ 1,820Volume1,080 shsAverage Volume2,666 shsMarket Capitalization£180.62 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsInsider TradesStock AnalysisChartCompetitorsInsider Trades Get 4basebio alerts: Email Address Ad Golden CrestBiden's Successor: The Radical Threat to YOUR Savings!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.>> Get Your FREE Wealth Protection Guide << About 4basebio4basebio PLC engages in the research, development, manufacturing, and commercialization of synthetic DNA and RNA products, and targeted non-viral vector solutions in the United States, Europe, and internationally. It provides AVV and Lentivirus manufacturing services for use in gene therapies and vaccines. The company offers access to its targeted non-viral delivery platform, Hermes. It serves biotech, pharma, and contract development and manufacturing organization. The company was formerly known as 4basebio UK Societas and changed its name to 4basebio PLC in July 2021. 4basebio PLC was founded in 2008 and is based in Cambridge, the United Kingdom.Read More 4BB Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart 4BB Stock News HeadlinesAugust 8, 2024 | finanznachrichten.de4basebio Plc - Strategic Advisory Board & Appointment of DirectorMay 13, 2023 | finance.yahoo.com4basebio Full Year 2022 Earnings: Revenues DisappointSeptember 7, 2024 | Crypto 101 Media (Ad)Perfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying with both fists. They know it's only a matter of time before another bull run. Now, Crypto Insiders Are Scooping up Lesser-Known Coins and Making Serious BankApril 3, 2023 | finanznachrichten.de4basebio Plc - New lease and expansion of manufacturing capacityFebruary 9, 2023 | finanznachrichten.de4basebio Plc - Exercise of Options and Issue of EquitySeptember 30, 2022 | uk.finance.yahoo.com4basebio Plc - Half-year ReportJune 10, 2022 | uk.finance.yahoo.com4basebio Plc - Research CollaborationJune 9, 2022 | uk.finance.yahoo.com4basebio Plc - Result of AGMSeptember 7, 2024 | Crypto 101 Media (Ad)Perfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying with both fists. They know it's only a matter of time before another bull run. Now, Crypto Insiders Are Scooping up Lesser-Known Coins and Making Serious BankMay 11, 2022 | uk.finance.yahoo.com4basebio Plc - Director/PDMR ShareholdingApril 27, 2022 | uk.finance.yahoo.com4basebio Plc - Joint Development Agreement with Heqet TherapeuticsJanuary 5, 2022 | investing.com4BASEBIO UK SOCIETAS (4BB)October 20, 2021 | finance.yahoo.comWhat Type Of Shareholders Make Up 4basebio PLC's (LON:4BB) Share Registry?See More Headlines Receive 4BB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for 4basebio and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:4BB CUSIPN/A CIKN/A Webwww.4basebio.com Phone44 1223 967 943FaxN/AEmployees78Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.62) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-7,670,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-231.29% Return on Assets-43.23% Debt Debt-to-Equity Ratio201.47 Current Ratio2.21 Quick Ratio3.52 Sales & Book Value Annual Sales£311,000.00 Price / Sales580.77 Cash FlowGBX 87.69 per share Price / Cash Flow16.08 Book ValueGBX (4) per share Price / Book-352.50Miscellaneous Outstanding Shares12,810,000Free FloatN/AMarket Cap£180.62 million OptionableNot Optionable Beta1.12 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesDr. Heikki Lanckriet Ph.D. (Age 47)CEO, Chief Scientific Officer & Executive Director Comp: $448.9kMr. David Roth (Age 57)CFO, Company Secretary & Executive Director Comp: $323.1kMr. Mark CooperHead of ManufacturingKey CompetitorsErgomedLON:ERGOSilence TherapeuticsLON:SLNPureTech HealthLON:PRTCOxford BiomedicaLON:OXBHorizon Discovery Group plc (HZD.L)LON:HZDView All Competitors 4BB Stock Analysis - Frequently Asked Questions How have 4BB shares performed this year? 4basebio's stock was trading at GBX 680 at the start of the year. Since then, 4BB stock has increased by 107.4% and is now trading at GBX 1,410. View the best growth stocks for 2024 here. How do I buy shares of 4basebio? Shares of 4BB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:4BB) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 4basebio PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share 4basebio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.